Rapid Micro Biosystems (RPID) Income from Continuing Operations (2020 - 2026)

Rapid Micro Biosystems has disclosed Income from Continuing Operations across 7 years of filings, most recently posting 14275000.0 for Q1 2026.

• Income from Continuing Operations for Q1 2026 came in at 14275000.0, down 26.74% year-over-year; the trailing twelve-month figure through Mar 2026 was 50135000.0 (down 11.83% YoY), and the FY2025 annual result was 47123000.0, changed 0.5% from the prior year.
• Income from Continuing Operations came in at 14275000.0 for Q1 2026 at Rapid Micro Biosystems, down from 12497000.0 in the prior quarter.
• In the past five years, Income from Continuing Operations ranged from a high of 9666000.0 in Q4 2024 to a low of 16464000.0 in Q4 2022.
• The 5-year median for Income from Continuing Operations is 13103000.0 (2022), against an average of 13034705.88.
• Across the five-year window, Income from Continuing Operations jumped 34.61% in 2022 and retreated 29.29% in 2025, its largest moves.
• Rapid Micro Biosystems' Income from Continuing Operations stood at 16464000.0 in 2022, then surged by 32.14% to 11172000.0 in 2023, then grew by 13.48% to 9666000.0 in 2024, then retreated by 29.29% to 12497000.0 in 2025, then retreated by 14.23% to 14275000.0 in 2026.
• The last three Income from Continuing Operations figures came in at 14275000.0 (Q1 2026), 12497000.0 (Q4 2025), and 11505000.0 (Q3 2025), per Business Quant data.